OUR FACILITIES
WILL REMAIN OPEN & OPERATIONAL DURING THE COVID-19 PANDEMIC

2020 was an incredible year of growth for Cryoport, Inc. The acquisitions of CRYOPDP and MVE Biological Solutions dramatically increased our global network and capabilities, and we achieved a new record of supporting over 500 clinical trials worldwide. During a calamitous year in which the COVID-19 pandemic disrupted supply chains all over the planet, we provided continuous steadfast service to our customers, including our support for 26 COVID-19 vaccine trials.

Background information

On January 31, 2020, the United Kingdom (UK) officially withdrew from the European Union (EU).   An eleven-month transition period was enacted to negotiate trade terms between the UK and the EU, and this transition period expired on December 31, 2020.